Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_assertion type Assertion NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_head.
- NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_assertion description "[This mechanism also applies to hematopoietic cells transformed by other HOX genes, including CDX2, which is highly expressed in a majority of acute myeloid leukemias, thus providing a molecular approach based on GSK-3 inhibitory strategies to target HOX-associated transcription in a broad spectrum of leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_provenance.
- NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_assertion evidence source_evidence_literature NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_provenance.
- NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_assertion SIO_000772 20541704 NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_provenance.
- NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_assertion wasDerivedFrom befree-20140225 NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_provenance.
- NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_assertion wasGeneratedBy ECO_0000203 NP767788.RAL827rmEU7qfbzefQQl8bniM0J3nlRw6vRKgdNjjogis130_provenance.